Meeting
2011 ASCO Annual Meeting
Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05.
Authors
A. Zapatero
Department of Radiation Oncology, Hospital Universitario de la Princesa, Madrid, Spain
A. Zapatero , A. Guerrero , X. Maldonado , A. Alvarez , C. González San Segundo , A. Cabeza , V. Macías , F. Casas , A. Pedro-Olivé , S. Villa , A. Boladeras , M. L. Vazquez de La Torre , C. Martin de Vidales , F. A. Calvo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer
Track
Genitourinary Cancer
Sub Track
Prostate Cancer
Clinical Trial Registration Number
2005-000417-36
Citation
J Clin Oncol 29: 2011 (suppl; abstr 4580)
Abstract #
4580
Poster Bd #
2C
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
HSD3B1 genotype and response to androgen deprivation therapy for biochemical recurrence after radiotherapy for localized prostate cancer.
First Author: Jason W.D. Hearn
Poster
2019 Genitourinary Cancers Symposium
Optimizing the use of androgen deprivation therapy in men with localized intermediate risk prostate cancer in the era of modern dose-escalated radiation therapy.
First Author: Sagar Anil Patel
Poster
2018 ASCO Annual Meeting
Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.
First Author: Andrew Loblaw
Poster
2018 ASCO Annual Meeting
Long-term androgen deprivation, with or without radiotherapy, in locally-advanced prostate cancer: Updated results from a phase III randomized trial.
First Author: Paul Sargos